# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-268076
Filing Date
2025-11-06
Accepted
2025-11-06 07:16:01
Documents
74
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ivvd-20250930.htm iXBRL | 10-Q | 2599370
2 | EX-31.1 | ivvd-ex31_1.htm | EX-31.1 | 19385
3 | EX-32.1 | ivvd-ex32_1.htm | EX-32.1 | 11745
| Complete submission text file | 0001193125-25-268076.txt |  | 9924289

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | ivvd-20250930.xsd | EX-101.SCH | 1347917
76 | EXTRACTED XBRL INSTANCE DOCUMENT | ivvd-20250930_htm.xml | XML | 1794522

Mailing Address 209 CHURCH STREET NEW HAVEN CT 06510
Business Address 209 CHURCH STREET NEW HAVEN CT 06510 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40703 | Film No.: 251456136
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)